Report Code : CVMI29124523 | Published Date : Jan. 15, 2025
                                 
                                 Reasons To Buy
                                 
                                 Scope
                                 
                              - Amoy Diagnostics
 - Novogene
 - Sysmex Corporation
 - Abbott Molecular
 - Roche Diagnostics / F. Hoffmann‑La Roche
 - Qiagen N.V.
 - Illumina, Inc.
 - Agilent Technologies
 - Thermo Fisher Scientific
 - Agilent Technologies
 - Myriad Genetics
 
Asia-Pacific Companion Diagnostics Market Report
- 1. Asia-Pacific Companion Diagnostics Market Research Report
	
- 1.1 Study Objectives
 - 1.2 Asia-Pacific Companion Diagnostics Market - Overview
 - 1.3 Reason to Read This Report
 - 1.4 Methodology and Forecast Analysis
 
 - 2. Asia-Pacific Companion Diagnostics Market Research Report - Preface
	
- 2.1 Asia-Pacific Companion Diagnostics Market Research Report – Detailed Scope and Definitions
		
- 2.1.1 By Type
 - 2.1.2 By Application
 - 2.1.3 By End-user
 - 2.1.4 By Region
 
 
 - 2.1 Asia-Pacific Companion Diagnostics Market Research Report – Detailed Scope and Definitions
		
 - 3. Asia-Pacific Companion Diagnostics Market Dynamics
	
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
 - 3.2. Restraints – By Type, By Application, By End-user, By Country
 - 3.3. Opportunities – By Type, By Application, By End-user, By Country
 - 3.4. Trends – By Type, By Application, By End-user, By Country
 - 3.5. PEST Analysis
 - 3.6. Porters Five Rule Analysis
 - 3.7. Company’s Share Analysis (CSA) by Region or By Country
 - 3.8. Asia-Pacific Companion Diagnostics Market Research Report – DROTs Impact Analysis
 
 
- 
	
- 4. Asia-Pacific Companion Diagnostics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
 - 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
 - 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
 - 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 5. Asia-Pacific Companion Diagnostics Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) 
	
- 5.1 Genetic Tests
 - 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 5.2 Protein Biomarker Tests
 - 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 5.3 Companion Drug Tests
 - 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 6.1 Oncology
 - 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 6.2 Neurology
 - 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 6.3 Infectious Diseases
 - 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 6.4 Cardiology
 - 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
- 7.1 Hospitals
 - 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 7.2 Clinics
 - 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 - 7.3 Research Institutes
 - 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
- 8. Asia-Pacific Companion Diagnostics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn) 
	
- 8.1 Asia-Pacific
		
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
 - 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
 - 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
 - 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
 
 
 - 8.1 Asia-Pacific
		
 
- 9. Asia-Pacific Asia-Pacific Companion Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) 
	
- 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
- 9.1.1 Genetic Tests
 - 9.1.2 Protein Biomarker Tests
 - 9.1.3 Companion Drug Tests
 
- 9.2.1 Oncology
 - 9.2.2 Neurology
 - 9.2.3 Infectious Diseases
 - 9.2.4 Cardiology
 
- 9.3.1 Hospitals
 - 9.3.2 Clinics
 - 9.3.3 Research Institutes
 
- 9.4.1 China
 - 9.4.2 Japan
 - 9.4.3 India
 - 9.4.4 South Korea
 - 9.4.5 Australia & NZ
 - 9.4.6 ASEAN
 - 9.4.7 Rest of Asia-Pacific
 
 - 9.5 Asia-Pacific Asia-Pacific Companion Diagnostics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
 - 9.6 Regional Trends Analysis
 - 9.7 Asia-Pacific Asia-Pacific Companion Diagnostics Market Research Report - Company Profiles
		
- 9.7.1 Company 1 (China)
 - 9.7.2 Company 2 (Japan)
 - 9.7.3 Company 3 (Japan)
 
 
- 10.1 Strategic Dashboard of Top Market Players
 - 10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
		
- 10.2.1 Amoy Diagnostics
 - 10.2.2 Novogene
 - 10.2.3 Sysmex Corporation
 - 10.2.4 Abbott Molecular
 - 10.2.5 Roche Diagnostics / F. Hoffmann‑La Roche
 - 10.2.6 Qiagen N.V.
 - 10.2.7 Thermo Fisher Scientific
 - 10.2.8 Illumina Inc.
 - 10.2.9 Agilent Technologies
 - 10.2.10 Agilent Technologies
 - 10.2.11 Myriad Genetics
 
 
 - 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
		
 
- 11. Data Collection Method and Research Approach
 
- 12. Principal Presumptions and Acronyms